Anlageschwerpunkt AZ Fund 1-AZ Equity - Global Healthcare - A-AZ EUR ACC
Wir holen für dich die Verwaltungsvergütungen beim Fondssparen zurück und zahlen dir die Bestandsprovisionen, auch für bereits gekaufte Fonds, aus.
Zusammensetzung nach Branchen
Zusammensetzung nach Land
Zusammensetzung nach Instrument
Top Holdings zu AZ Fund 1-AZ Equity - Global Healthcare - A-AZ EUR ACC
| Wertpapiername | Anteil |
|---|---|
| ELI LILLY & CO | 7,10 % |
| JOHNSON & JOHNSON | 6,90 % |
| UNITEDHEALTH GROUP INC | 6,20 % |
| MERCK & CO. INC. | 5,20 % |
| NOVO NORDISK A/S-B | 4,50 % |
| ABBVIE INC | 4,40 % |
| ASTRAZENECA PLC | 3,90 % |
| DANAHER CORP | 3,90 % |
| ROCHE HOLDING AG-GENUSSCHEIN | 3,80 % |
| THERMO FISHER SCIENTIFIC INC | 3,80 % |
| Summe: | 49,70 % |
Fondsstrategie zu AZ Fund 1-AZ Equity - Global Healthcare - A-AZ EUR ACC
The Sub-fund's investment objective is to achieve long-term capital growth. The Sub-fund aims to achieve its investment objective by actively managing a diversified portfolio of equities issued by companies worldwide involved in the research, development, production and sale of pharmaceutical, medical and biomedical products. The Sub-fund invests directly or indirectly at least 80% of its net assets in equities issued by companies involved in the research, development, production and sale of pharmaceutical, medical and biomedical products. Indirect exposure is obtained by investing in derivatives based on equities and/or equity indices in order to adjust the overall exposure of the Sub-fund's portfolio. The Sub-fund may also invest up to 40% of its net assets in equities issued by companies headquartered and/or primarily doing business in an emerging market.